BWM Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Sell
1,188
-20
-2% -$20.3K 0.29% 45
2025
Q4
$1.3M Buy
1,208
+39
+3% +$37.3K 0.35% 42
2025
Q3
$892K Buy
1,169
+28
+2% +$20.8K 0.27% 47
2025
Q2
$889K Buy
1,141
+112
+11% +$87K 0.31% 46
2025
Q1
$850K Hold
1,029
0.36% 44
2024
Q4
$794K Hold
1,029
0.35% 47
2024
Q3
$912K Buy
+1,029
New +$925K 0.4% 45

Other funds holding LLY

BWM Planning's LLY Position: Q1 2026 in Review

BWM Planning reduced its Eli Lilly (LLY) stake by 1.7% in Q1 2026, selling an estimated $20.3K and leaving 1,188 shares worth $1.09M. The position accounts for 0.29% of the portfolio, ranked #45.

BWM Planning first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.3M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • BWM Planning held 1,188 shares of Eli Lilly worth $1.09M as of Q1 2026.
  • BWM Planning sold 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 0.29% of BWM Planning's portfolio in Q1 2026, its #45 holding.
  • BWM Planning first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • BWM Planning's Eli Lilly position peaked at $1.3M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BWM Planning's 13F filing for Q1 2026, filed 22 Apr 2026.